Community Care Rx Revenue and Competitors
Estimated Revenue & Valuation
- Community Care Rx's estimated annual revenue is currently $16.7M per year.
- Community Care Rx's estimated revenue per employee is $201,000
Employee Data
- Community Care Rx has 83 Employees.
- Community Care Rx grew their employee count by 5% last year.
Community Care Rx's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | VP Corporate Development | Reveal Email/Phone |
3 | VP Operations | Reveal Email/Phone |
4 | VP Client Relations | Reveal Email/Phone |
5 | VP Client Relations | Reveal Email/Phone |
6 | Director Human Resources | Reveal Email/Phone |
7 | Accounts Receivable Manager | Reveal Email/Phone |
8 | Inventory Manager | Reveal Email/Phone |
9 | Senior Staff Pharmacist | Reveal Email/Phone |
10 | Client Services | Reveal Email/Phone |
Community Care Rx Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $13.1M | 65 | 7% | N/A | N/A |
#2 | $354.3M | 484 | -2% | $567.1M | N/A |
#3 | $347.1M | 1727 | -8% | N/A | N/A |
#4 | $8.8M | 44 | 13% | N/A | N/A |
#5 | $6M | 30 | 11% | N/A | N/A |
#6 | $46.6M | 232 | 4% | N/A | N/A |
#7 | $6.6M | 33 | -3% | N/A | N/A |
#8 | $11.3M | 56 | 12% | N/A | N/A |
#9 | $168.8M | 840 | 46% | N/A | N/A |
#10 | $12.3M | 61 | -21% | N/A | N/A |
What Is Community Care Rx?
Community Care Rx is a long-term care pharmacy that serves Adult & Pediatric Residential Programs, Assisted Living Facilities, Hospital Discharge Programs, HIV Programs, Hospital and Nursing Home Discharges and Skilled Nursing Facilities.
keywords:N/AN/A
Total Funding
83
Number of Employees
$16.7M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $17M | 83 | -1% | N/A |
#2 | $3.5M | 87 | 4% | N/A |
#3 | $21.1M | 87 | -5% | N/A |
#4 | $21.5M | 105 | 22% | N/A |
#5 | $30M | 111 | 8% | N/A |
